Morgan Stanley’s T-REX 2X Inverse CRCL Daily Target ETF CRCD Stock Holding History

Morgan Stanley’s Portfolio CRCD Stock Details CRCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14K	Buy	+169	New	+$4.63K	﹤0.01%	7415

Other funds holding CRCD

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley's CRCD Position: Q1 2026 in Review

Morgan Stanley opened a new position in T-REX 2X Inverse CRCL Daily Target ETF (CRCD) in Q1 2026: 169 shares worth $1.14K. The stake represents ﹤0.01% of the portfolio and ranks #7415 among its holdings.

8 funds tracked by Wall St. Rank hold CRCD as of Q1 2026.

Morgan Stanley held 169 shares of T-REX 2X Inverse CRCL Daily Target ETF worth $1.14K as of Q1 2026.
T-REX 2X Inverse CRCL Daily Target ETF was a new Morgan Stanley position in Q1 2026.
T-REX 2X Inverse CRCL Daily Target ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7415 holding.
8 funds tracked by Wall St. Rank held T-REX 2X Inverse CRCL Daily Target ETF as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.